Assessing Progress Towards an Interoperable European eHealth Space

empirica (Gesellschaft für Kommunikations- und Technologieforschung mbH)Fostering the development and implementation of national eHealth policies and strategies has been a key goal of the European Union (EU) eHealth Action Plan of 2004. To review progress made and analyse the results so far obtained by EU Member States, the European Commission just before Christmas signed a contract with Bonn-based eHealth specialist empirica.

"We are more than happy that we won this prestigious project in a competitive tender, which will update part of the very comprehensive survey work undertaken earlier by the so-called eHealth ERA project" said Dr. Veli Stroetmann, senior research fellow with empirica Communication and Technology Research, who is a principal investigator for this new work. Some key results of that earlier study were summarised in the EU report on "eHealth priorities and strategies in European countries".

The objectives of the new study are to measure and assess Union Member States eHealth progress:

  • whether national eHealth policies, strategies, roadmaps and/or implementation measures exist and have been updated;
  • whether and to what extent the objectives defined in the European eHealth Action plan have been incorporated into them;
  • what progress has been achieved, focusing on eHealth Action Plan priorities;
  • which (further) national priorities and actions may support the accelerated realisation of the eHealth Action Plan.

The final output, expected during the middle of 2010, will involve a comprehensive progress report with country briefs and policy recommendations on Member States eHealth policy progress towards an interoperable European eHealth space.

Special advisor to the study and contributor will be Prof. Denis Protti of the University of Victoria, Canada, a global expert on the comparative analysis of national and regional eHealth implementations. Contributing partners are the Finnish National Institute for Health and Welfare (THL, the former STAKES), and European law firm Time.Lex CVBA as well as further expert institutes in all the more than 30 countries to be covered by this extensive research.

Related news articles:

About empirica
empirica Gesellschaft für Kommunikations- und Technologieforschung mbH (empirica) has many years of experience in quantitative and qualitative research methods. Its clients are private companies and public bodies: large and medium-sized companies in the insurance, pharmaceutical and automobile industries as well as software developers and hardware manufacturers. There are also telecommunications service companies and network providers, social services firms, medical facilities, Federal and State Government ministries in Germany and the European Commission as well as the European statistical office (Eurostat). For further information, please visit www.empirica.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...